Mexico: Some Considerations Related With the Ethics in the Patentability of Biotechnology Related Inventions in Mexico

Last Updated: 7 October 2005
Article by Norma Garcia-Calderon

Most Read Contributor in Mexico, November 2018

New technologies derived from biological sciences, particularly those related with genetically modified organisms (GMOs), have generated ethical concerns in Patent Offices worldwide. As Mexico is not an exception, there is no doubt that some modifications to its Industrial Property Law in order to establish an ethical framework for the patentability of these new emerging technologies must be briefly carried out.

So far, the Mexican Industrial Property Law (MIPL) allows the patentability of a wide range of inventions in the genetic field, comprising processes and products, as far as they comply with the general requirements of novelty, inventive step, industrial applicability and also sufficiency in the specification and reproducibility (utility and enablement).

As an example of the above, the following subject matter could be considered as patentable:

  • Genes or partial DNA sequences.
  • Proteins codified by said genes and their role in the organism.
  • Vectors for the transference of genes.
  • Microorganisms, cells, and genetically modified plants and non-human animals.
  • Processes for creating GMOs.
  • The use of genetic sequences or proteins for diagnosing diseases or predisposition to disease.
  • Medicaments based on the knowledge derived from the proteins and their biological activity.

Thus, a claim belonging to a biotechnology related invention may comprise:

Products: peptides and proteins; antibodies (including monoclonal); genes; DNA and RNA sequences (promoters, enhancers, oligonucleotides, anti-sense sequences, plasmids, etc.); pharmaceutical products derived thereof.

Biological material: classic microorganisms (bacteria, yeasts, algae, virus, phages); human and animal cell lines; plant cell lines; GM non-human animals and GM plants.

Apparatuses: kits

Processes: for preparing proteins, genes, DNA or RNA molecules, microorganisms, cell lines, pharmaceutical products, or processes for producing products by fermentation.

However, even if the above matter may satisfy the patentability requirements stated by law, the ethical aspect of the same would still have to be evaluated.

Within the MIPL, Article 4 is the only one related with the patentability and ethics of inventions. Said article 4 reads as follows in translation:

A patent, registration or authorization shall not be granted, nor shall publication be given in the Gazette to any of the legal figures or institutions that regulate this Law, when the contents or form may be contrary to public order, morality or good practices, or they violate any legal provision.

As the recitation of Article 4 is not quite clear and concise, the terms "morality" and "good practices" may be interpreted in many different ways, thus leaving to the criterion of the Mexican Institute of Industrial Property (MIIP) the patentability of this type of inventions.

During the last years, the MIIP, through the biotechnology substantive examination section, has been carefully studying and discussing how to handle this subject matter, whereby in the case of new emerging biotechnology related inventions, the Mexican authorities will consider and evaluate the following:

  • Animal suffering: It should be considered if the genetic animal modification provokes suffering with or without medical utility for the human kind or animals. In case that there is not any medical benefit, the process and the animal obtained there from will not be patentable.
  • <
  • The environmental impact or risk. It should be evaluated in light of the specification if there is a negative impact of the claimed product or process, and in case of a potential damage to the environment, as the case may be, genetic contamination, it will be considered as a non patentable invention.
  • The utility of the invention for humanity.

According to the above and to the general ethical principles adopted around the world, the following matter is not considered as patentable by our authorities:

  • Human being cloning processes;
  • Processes for modifying the germinal genetic identity of a human being; and
  • The use of human embryos for commercial or industrial purposes.

In addition to the above, it is important to remind that Article 16 of the MIPL lists those inventions also excluded from patentability:

  1. Essentially biological processes for the production, reproduction and propagation of plants and animals (that is, mere breeding processes).
  2. Biologic and genetic materials such as they are found in nature (that is, only those materials in which no human intervention may be claimed).
  3. Animal races (that is, those obtained by breeding, which means that transgenic animals are patentable).
  4. The human body and the living parts constituting the same.
  5. Plant varieties. (However, a new law for the protection of breeders' rights is presently in existence, under which all types of plant varieties can be protected).

As the Mexican Institute of Industrial Property (MIIP) is trying to standardize the criteria on biotechnology patent applications, those related to transgenic plants and some related to transgenic animals are and will continue being examined, however, patent applications concerning cloning procedures will not be liberated to examination until the Mexican Authorities reach a final handling criterion for said applications.

Nevertheless, it is believed that the MIIP will finally agree with the European criteria, which are reflected in Articles 53, 52, and 83 and Rules 23 c(a), e(2,3), 27 (1)(e,f) of the European Patent Convention (EPC/CPE). These Articles and Rules refer to patentable matter, animal suffering, human benefit, morality and environmental risks as set forth in above paragraphs.

In view of the above, it can be concluded that there are no precise rules to accurately ascertain the conditions that patent applications for biotechnological emerging products or processes must be met in order to comply with the Mexican Law and practice. The above paragraphs simply show a general view of the Mexican legislation on this type of applications in order to permit the applicant to make the better decision.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions